- Lonza looks to ride ADC wave with upcoming factory, workforce expansionBASEL, Switzerland — Lonza said it wants to own the commercial market for antibody-drug conjugates, with a new manufacturing site set to come online next year and plans to increase its headcount.…Endpoints · 2mo ago↗ source
- Madrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts🚀 Madrigal Pharmaceuticals' MASH drug beats expectations: The biotech’s Rezdiffra sales came in at $311 million for the first quarter, surpassing analysts’ projections by about $10 million, accord…Endpoints · 2mo ago↗ source
- Former Orbital scientists launch new mRNA therapy startupTwo scientists think they've solved a technical problem that has kept the mRNA revolution from reaching its full potential. Now, they're launching ParcelBio with $13 million in seed funding to dev…